CRISIL upgrades ratings of Bafna Pharmaceuticals’ bank facilities

19 Nov 2014 Evaluate

Credit rating agency, CRISIL has upgraded rating of Bafna Pharmaceuticals’ long term bank facilities to ‘BB-’ from ‘D’. The rating agency has also upgraded rating of the company’s short term bank facilities to ‘A4+’ from ‘D’.

Bafna Pharmaceutical is a Chennai-based Pharma company engaged in the manufacturing of pharmaceutical formulations of Betalactum and Non-Betalactum. The company has 173 products registered in UK, Sri Lanka, Nepal, Ukraine, Ghana, Ethiopia, Philippines, Kryghistan, Georgia, Honduras, Colombia, Uzbekhistan, Vietnam and Nigeria.

Bafna Pharma Share Price

149.40 -3.00 (-1.97%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×